{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:26:18Z","timestamp":1778725578958,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s11547-017-0824-9","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T11:04:59Z","timestamp":1509534299000},"page":"217-226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparison of intensity modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) and a 3-dimensional conformal parotid gland-sparing radiotherapy (ConPas 3D-CRT) in treatment of nasopharyngeal carcinoma: a mono-institutional experience"],"prefix":"10.1007","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2826-9664","authenticated-orcid":false,"given":"Vesna","family":"Bi\u0161of","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoran","family":"Raku\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juraj","family":"Bibi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timor","family":"Grego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majana","family":"So\u010de","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"key":"824_CR1","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer. http:\/\/globocan.iarc.fr . Accessed 6 May 2017"},{"key":"824_CR2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2016.01.040","volume":"374","author":"LL Tang","year":"2016","unstructured":"Tang LL, Chen WQ, Xue WQ, He YQ, Zheng RS, Zeng YX et al (2016) Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett 374:22\u201330","journal-title":"Cancer Lett"},{"key":"824_CR3","unstructured":"www.cancer.org\/cancer\/nasopharyngeal-cancer\/detection-diagnosis-staging\/survival-rates.html . Accessed 6 May 2017"},{"key":"824_CR4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11547-016-0722-6","volume":"122","author":"L Lastrucci","year":"2017","unstructured":"Lastrucci L, Bertocci S, Bini V, Borghesi S, De Majo R, Rampini A et al (2017) Late toxicity, evolving radiotherapy techniques, and quality of life in nasopharyngeal carcinoma. Radiol Med 122:303\u2013308","journal-title":"Radiol Med"},{"key":"824_CR5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","volume":"104","author":"G Peng","year":"2012","unstructured":"Peng G, Wang T, Yang KY, Zhang S, Zhang T, Li Q et al (2012) A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol 104:286\u2013293","journal-title":"Radiother Oncol"},{"key":"824_CR6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0360-3016(03)00075-0","volume":"56","author":"MK Kam","year":"2003","unstructured":"Kam MK, Chau RM, Suen J, Choi PH, Teo PM (2003) Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 56:145\u2013157","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"824_CR7","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1200\/JCO.2007.11.5501","volume":"25","author":"MK Kam","year":"2007","unstructured":"Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F et al (2007) Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 25:4873\u20134879","journal-title":"J Clin Oncol"},{"key":"824_CR8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2006.06.013","volume":"66","author":"EH Pow","year":"2006","unstructured":"Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH et al (2006) Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66:981\u2013991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"824_CR9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0360-3016(91)90030-8","volume":"20","author":"SA Leibel","year":"1991","unstructured":"Leibel SA, Kutcher GJ, Harrison LB, Fass DE, Burman CM, Hunt MA et al (1991) Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 20:823\u2013833","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"824_CR10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0360-3016(00)00702-1","volume":"48","author":"K Sultanem","year":"2000","unstructured":"Sultanem K, Shu HK, Xia P, Akazawa C, Quivey JM, Verhey LJ et al (2000) Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 48:711\u2013722","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"824_CR11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ijrobp.2007.12.054","volume":"72","author":"FM Fang","year":"2008","unstructured":"Fang FM, Chien CY, Tsai WL, Chen HC, Hsu HC, Lui CC et al (2008) Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy\u2014a longitudinal study. Int J Radiat Oncol Biol Phys 72:356\u2013364","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"824_CR12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s12094-012-0864-5","volume":"14","author":"WL Kuang","year":"2012","unstructured":"Kuang WL, Zhou Q, Shen LF (2012) Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma. Clin Transl Oncol 14:783\u2013790","journal-title":"Clin Transl Oncol"},{"key":"824_CR13","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s11547-013-0359-7","volume":"119","author":"F Moretto","year":"2014","unstructured":"Moretto F, Rampino M, Munoz F, Ruo Redda MG, Reali A, Balcet V et al (2014) Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment. Radiol Med 119:634\u2013641","journal-title":"Radiol Med"},{"key":"824_CR14","doi-asserted-by":"crossref","first-page":"e94456","DOI":"10.1371\/journal.pone.0094456","volume":"9","author":"MT Spiotto","year":"2014","unstructured":"Spiotto MT, Weichselbaum RR (2014) Comparison of 3D conformal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers. PLoS ONE 9:e94456","journal-title":"PLoS ONE"},{"key":"824_CR15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00066-005-1413-8","volume":"181","author":"R Wiggenraad","year":"2005","unstructured":"Wiggenraad R, Mast M, van Santvoort J, Hoogendoorn M, Struikmans H (2005) ConPas: a 3-D conformal parotid gland-sparing irradiation technique for bilateral neck treatment as an alternative to IMRT. Strahlenther Onkol 181:673\u2013682","journal-title":"Strahlenther Onkol"},{"key":"824_CR16","first-page":"1473","volume":"10","author":"ICRU","year":"2010","unstructured":"ICRU (2010) Report no 83. Prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT). J ICRU 10:1473\u20136691","journal-title":"J ICRU"},{"key":"824_CR17","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","volume":"27","author":"N Lee","year":"2009","unstructured":"Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P et al (2009) Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 27:3684\u20133690","journal-title":"J Clin Oncol"},{"key":"824_CR18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.radonc.2003.09.011","volume":"69","author":"V Gr\u00e9goire","year":"2003","unstructured":"Gr\u00e9goire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V et al (2003) CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69:227\u2013236","journal-title":"Radiother Oncol"},{"key":"824_CR19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2006.03.009","volume":"79","author":"V Gr\u00e9goire","year":"2006","unstructured":"Gr\u00e9goire V, Eisbruch A, Hamoir M, Levendag P (2006) Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 79:15\u201320","journal-title":"Radiother Oncol"},{"key":"824_CR20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","volume":"110","author":"V Gr\u00e9goire","year":"2014","unstructured":"Gr\u00e9goire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA et al (2014) Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol 110:172\u2013181","journal-title":"Radiother Oncol"},{"key":"824_CR21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.radonc.2013.10.035","volume":"110","author":"Y Sun","year":"2014","unstructured":"Sun Y, Yu XL, Luo W, Lee AW, Wee JT, Lee N et al (2014) Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy. Radiother Oncol 110:390\u2013397","journal-title":"Radiother Oncol"},{"key":"824_CR22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","volume":"117","author":"CL Brouwer","year":"2015","unstructured":"Brouwer CL, Steenbakkers RJ, Bourhis J, Budach W, Grau C et al (2015) CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiother Oncol 117:83\u201390","journal-title":"Radiother Oncol"},{"issue":"3 Suppl","key":"824_CR23","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A et al (2010) Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 76(3 Suppl):S10\u2013S19","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"824_CR24","unstructured":"R Core Team (2008) R: A language and environment for statistical computing. R Foundation for statistical computing, Vienna, France"},{"key":"824_CR25","unstructured":"Therneau T (2015) A Package for Survival Analysis in S. Version 2.38. https:\/\/CRAN.Rproject.org\/package=survival . Accessed 13 Apr 2017"},{"key":"824_CR26","doi-asserted-by":"crossref","unstructured":"Kassambara A, Kosinski M (2017) Survimner: drawing survival curves using \u201cggplot2\u201d. R package version 0.3.1","DOI":"10.32614\/CRAN.package.survminer"},{"key":"824_CR27","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-98141-3","volume-title":"Ggplots2: elegant graphics for data analysis","author":"H Wickam","year":"2009","unstructured":"Wickam H (2009) Ggplots2: elegant graphics for data analysis. Springer, New York"},{"key":"824_CR28","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0360-3016(03)01569-4","volume":"57","author":"N Dogan","year":"2003","unstructured":"Dogan N, King S, Emami B, Mohideen N, Mirkovic N, Leybovich LB et al (2003) Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing. Int J Radiat Oncol Biol Phys 57:1480\u20131491","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"824_CR29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/0971-6203.111331","volume":"38","author":"MY Herrassi","year":"2013","unstructured":"Herrassi MY, Bentayeb F, Malisan MR (2013) Comparative study of four advanced 3D-conformal radiation therapy treatment planning techniques for head and neck cancer. J Med Phys 38:98\u2013105","journal-title":"J Med Phys"},{"key":"824_CR30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2014.02.003","volume":"110","author":"AW Lee","year":"2014","unstructured":"Lee AW, Ng WT, Chan LL, Hung WM, Chan CC, Sze HC et al (2014) Evolution of treatment for nasopharyngeal cancer\u2013success and setback in the intensity-modulated radiotherapy era. Radiother Oncol 110:377\u2013384","journal-title":"Radiother Oncol"},{"key":"824_CR31","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/1471-2407-13-318","volume":"13","author":"MM Fareed","year":"2013","unstructured":"Fareed MM, AlAmro AS, Bayoumi Y, Tunio MA, Ismail AS, Akasha R et al (2013) Intensity-modulated radiotherapy with simultaneous modulated accelerated boost technique and chemotherapy in patients with nasopharyngeal carcinoma. BMC Cancer 13:318","journal-title":"BMC Cancer"},{"key":"824_CR32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.rpor.2013.09.008","volume":"18","author":"J Gomez-Millan","year":"2013","unstructured":"Gomez-Millan J, Fern\u00e1ndez JR, Medina Carmona JA (2013) Current status of IMRT in head and neck cancer. Rep Pract Oncol Radiother 18:371\u2013375","journal-title":"Rep Pract Oncol Radiother"},{"key":"824_CR33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.anorl.2014.02.008","volume":"132","author":"S Haberer-Guillerm","year":"2015","unstructured":"Haberer-Guillerm S, Touboul E, Huguet F (2015) Intensity modulated radiation therapy in nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis 132:147\u2013151","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"824_CR34","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.7150\/jca.16476","volume":"7","author":"L Xu","year":"2016","unstructured":"Xu L, Yao JJ, Zhou GQ, Zhang WJ, Liu GL, Liu LZ et al (2016) The impact of clinical stage on radiation doses to organs at risk following intensity-modulated radiotherapy in nasopharyngeal carcinoma: a prospective analysis. J Cancer 7:2157\u20132164","journal-title":"J Cancer"},{"key":"824_CR35","first-page":"2142","volume":"7","author":"JJ Yao","year":"2016","unstructured":"Yao JJ, Chen FP, Zhou GQ, Zhang WJ, Xu L, Wang XJ et al (2016) A prospective study on radiation doses to organs at risk (OARs) during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients. Oncotarget 7:2142\u20132152","journal-title":"Oncotarget"},{"key":"824_CR36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0360-3016(99)00247-3","volume":"45","author":"A Eisbruch","year":"1999","unstructured":"Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA (1999) Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45:577\u2013587","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"824_CR37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","volume":"12","author":"CM Nutting","year":"2011","unstructured":"Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C et al (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12(2):127\u2013136","journal-title":"Lancet Oncol"},{"key":"824_CR38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s11547-015-0512-6","volume":"120","author":"R Mazzola","year":"2015","unstructured":"Mazzola R, Ferrera G, Alongi F, Mannino M, Abbate B, Cucchiara T et al (2015) Organ sparing and clinical outcome with step-and-shoot IMRT for head and neck cancer: a mono-institutional experience. Radiol Med 120:753\u2013758","journal-title":"Radiol Med"},{"key":"824_CR39","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","volume":"27","author":"N Lee","year":"2009","unstructured":"Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P et al (2009) Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 27:3684\u20133690","journal-title":"J Clin Oncol"},{"key":"824_CR40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2012.07.005","volume":"104","author":"SL Gulliford","year":"2012","unstructured":"Gulliford SL, Miah AB, Brennan S, McQuaid D, Clark CH, Partridge M et al (2012) Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial. Radiother Oncol 104:205\u2013212","journal-title":"Radiother Oncol"},{"key":"824_CR41","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.radonc.2013.06.042","volume":"110","author":"C Powell","year":"2014","unstructured":"Powell C, Schick U, Morden JP, Gulliford SL, Miah AB, Bhide S et al (2014) Fatigue during chemoradiotherapy for nasopharyngeal cancer and its relationship to radiation dose distribution in the brain. Radiother Oncol 110:416\u2013421","journal-title":"Radiother Oncol"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11547-017-0824-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-017-0824-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-017-0824-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T06:22:14Z","timestamp":1719555734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11547-017-0824-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["824"],"URL":"https:\/\/doi.org\/10.1007\/s11547-017-0824-9","relation":{},"ISSN":["0033-8362","1826-6983"],"issn-type":[{"value":"0033-8362","type":"print"},{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,1]]}}}